Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aclaris Therapts (ACRS)

Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Aclaris Therapeutics Announces Formation of New Scientific Advisory Board

ACRS : 2.50 (+2.88%)
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

ACRS : 2.50 (+2.88%)
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

ACRS : 2.50 (+2.88%)
Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference

ACRS : 2.50 (+2.88%)
Aclaris Therapeutics Stock Surges On Licensing Deal, $80 Million Private Placement: Retail Sentiment Jumps

Leerink upgraded Aclaris to ‘Outperform’ from ‘Market Perform’ with its price target raised to $7 from $2; Piper Sandler upgraded the company to ‘Overweight’ from ‘Neutral.’

VHT : 269.61 (-0.64%)
VXF : 198.92 (-0.87%)
VTI : 298.01 (-0.89%)
ACRS : 2.50 (+2.88%)
Aclaris Therapeutics Secures $80 Million in Private Placement of Common Stock

Aclaris Therapeutics announced a private placement of 35.56 million shares, raising approximately $80 million for R&D and corporate purposes.Quiver AI SummaryAclaris Therapeutics, Inc. announced that it...

ACRS : 2.50 (+2.88%)
Aclaris Therapeutics Expands Pipeline with Exclusive Biosion License Agreement and Strengthens Leadership Team

Aclaris expands its pipeline with Biosion's innovative biologics, enhancing leadership and financial position for future growth.Quiver AI SummaryAclaris Therapeutics has announced a strategic advancement...

ACRS : 2.50 (+2.88%)
Aclaris Therapeutics Announces $80 Million Private Placement

ACRS : 2.50 (+2.88%)
Aclaris Therapeutics Announces Exclusive, Global License Agreement with Biosion, Inc., adding Potential Best-in-Class Biologics Assets to Pipeline

ACRS : 2.50 (+2.88%)
Aclaris: Q3 Earnings Snapshot

Aclaris: Q3 Earnings Snapshot

ACRS : 2.50 (+2.88%)

Barchart Exclusives

Hilton Gets Unusual Options Activity Just In Time for Super Bowl Weekend
Super Bowl weekend is upon us. The big game is set for Sunday evening in New Orleans. It’s only appropriate then that Hilton had the most unusually active option in Thursday trading. And it’s a good one. Here’s why. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar